shutterstock_1197728128_photobyphm-jpg
photobyphm / Shutterstock.com
13 August 2020Big PharmaMuireann Bolger

Bayer, Apotex settle suit over cancer drug patent

Bayer Healthcare Pharmaceuticals has settled a patent infringement suit with generics manufacturer  Apotex, after claiming that its version of a cancer treatment infringed two patents for cancer drug  Stivarga (regorafenib).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
15 March 2019   Doctors’ handwriting poses a significant challenge to the registration of pharmaceutical trademarks, according to a senior counsel at German pharmaceutical company Bayer.
Americas
26 August 2020   Intercept Pharmaceuticals is suing Canadian generics manufacturer Apotex over a proposed version of autoimmune drug Ocaliva.
Americas
27 October 2020   Germany-based Bayer will pay up to $4 billion to acquire gene therapy company Asklepios BioPharmaceutical.

More on this story

Big Pharma
15 March 2019   Doctors’ handwriting poses a significant challenge to the registration of pharmaceutical trademarks, according to a senior counsel at German pharmaceutical company Bayer.
Americas
26 August 2020   Intercept Pharmaceuticals is suing Canadian generics manufacturer Apotex over a proposed version of autoimmune drug Ocaliva.
Americas
27 October 2020   Germany-based Bayer will pay up to $4 billion to acquire gene therapy company Asklepios BioPharmaceutical.

More on this story

Big Pharma
15 March 2019   Doctors’ handwriting poses a significant challenge to the registration of pharmaceutical trademarks, according to a senior counsel at German pharmaceutical company Bayer.
Americas
26 August 2020   Intercept Pharmaceuticals is suing Canadian generics manufacturer Apotex over a proposed version of autoimmune drug Ocaliva.
Americas
27 October 2020   Germany-based Bayer will pay up to $4 billion to acquire gene therapy company Asklepios BioPharmaceutical.